Laman UtamaORCHPHARMA • NSE
add
Orchid Pharma Ltd
Tutup sebelumnya
₹714.30
Julat hari
₹715.15 - ₹749.10
Julat tahun
₹603.80 - ₹1,997.40
Permodalan pasaran
37.51B INR
Bilangan Purata
197.26K
Nisbah P/E
37.63
Hasil dividen
-
Pertukaran utama
NSE
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (INR) | Mac 2025info | Perubahan T/T |
|---|---|---|
Hasil | 2.37B | 9.39% |
Perbelanjaan pengendalian | 803.51J | 65.13% |
Pendapatan bersih | 222.95J | -33.50% |
Margin untung bersih | 9.39 | -39.18% |
Pendapatan bagi setiap syer | 4.40 | — |
EBITDA | 277.48J | -6.06% |
Kadar cukai berkesan | -0.18% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (INR) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 1.80B | 4,868.40% |
Jumlah aset | 16.88B | 8.63% |
Jumlah liabiliti | 4.21B | 9.42% |
Jumlah ekuiti | 12.67B | — |
Syer tertunggak | 50.67J | — |
Harga kepada buku | 2.86 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 3.38% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (INR) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 222.95J | -33.50% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Diasaskan
1992
Tapak web
Pekerja
871
